Enduring Clinical Remission in Refractory Celiac Disease Type II With Tofacitinib: An Open-Label Clinical Study

被引：5
|
作者：
Dieckman, Tessa [1 ,2 ]
Schumann, Michael [3 ]
Beaumont, Hanneke [2 ]
Bontkes, Hetty j. [4 ]
Koning, Frits [1 ]
Bouma, Gerd [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Immunol, Leiden, Netherlands
[2] Vrije Univ Amsterdam Amsterdam Gastroenterol Endoc, Dept Gastroenterol & Hepatol, Amsterdam UMC, Amsterdam, Netherlands
[3] Charite Univ Med Berlin, Div Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, Berlin, Germany
[4] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam UMC locat, Lab Specialized Diagnost & Res,Dept Lab Med,Med Im, Amsterdam, Netherlands
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 22卷 / 11期
关键词：
BUDESONIDE;
D O I：
10.1016/j.cgh.2024.05.022
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2334 / 2336
页数：3
相关论文
共 50 条
  • [21] Certolizumab Pegol Induces Clinical Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: An Open-Label Study
    Lee, Scott D.
    Clark-Snustad, Kindra
    Parrott, Susan
    Singla, Anand
    Osterman, Mark T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S425 - S425
  • [22] Long Term Open Label Extension of Study of Tofacitinib in Refractory Dermatomyositis
    Paik, Julie
    Albayda, Jemima
    Tiniakou, Eleni
    Purwin, Grazyna
    Koenig, Andrew
    Christopher-Stine, Lisa
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [23] An open-label clinical trial of nefazodone in hypochondriasis
    Kjernisted, KD
    Enns, MW
    Lander, M
    PSYCHOSOMATICS, 2002, 43 (04) : 290 - 294
  • [24] Rituximab for refractory polymyositis: An open-label prospective study
    Mok, Chi Chiu
    Ho, Ling Yin
    To, Chi Hung
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (09) : 1864 - 1868
  • [25] ASSESSING THE IMPACT OF ASTHMA CONTROL QUESTIONNAIRE SCORE CUTOFFS WITHIN THE MULTICOMPONENT CLINICAL REMISSION ENDPOINT ON CLINICAL OUTCOMES: TRAVERSE OPEN-LABEL STUDY
    Pavord, Ian D.
    Peters, Anju T.
    Porsbjerg, Celeste
    Castro, Mario
    Virchow, J. C.
    Couillard, Simon
    Xia, Changming
    Gall, Rebecca
    Pandit-Abid, Nami
    Rowe, Paul J.
    Deniz, Yamo
    Jacob-Nara, Juby A.
    Sacks, Harry
    CHEST, 2024, 166 (04) : 4797A - 4800A
  • [26] Rituximab for refractory polymyositis: An open-label prospective study
    Mok, C. C.
    Ho, L. Y.
    To, C. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 216 - 216
  • [27] Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression
    Parikh, Sagar V.
    Vande Voort, Jennifer L.
    Yocum, Anastasia K.
    Achtyes, Eric
    Goes, Fernando S.
    Nykamp, Louis
    Singh, Balwinder
    Lopez-Vives, Daniela
    Sera, Cortney E.
    Maixner, Daniel
    Tarnal, Vijay
    Severe, Jennifer
    Bartek, Steven
    Tye, Susannah J.
    Rico, Jose
    Stoppel, Cynthia J.
    Becerra, Alexis
    Smart, LeAnn
    Miller, Christina R.
    Frye, Mark A.
    Greden, John F.
    Bobo, William V.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 348 : 143 - 151
  • [28] The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study
    Frew, John W.
    Navrazhina, Kristina
    Grand, David
    Sullivan-Whalen, Mary
    Gilleaudeau, Patricia
    Garcet, Sandra
    Ungar, Jonathan
    Krueger, James G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) : 1341 - 1348
  • [29] TOCILIZUMAB IN REFRACTORY TAKAYASU ARTERITIS. OPEN-LABEL NATIONAL MULTICENTER STUDY OF 53 PATIENTS OF CLINICAL PRACTICE
    Prieto-Pena, D.
    Calderon-Goercke, M.
    Bernabeu, P.
    Vela-Casasempere, P.
    Narvaez, J.
    Fernandez-Lopez, C.
    Freire Gonzalez, M.
    Gonzalez-Alvarez, B.
    Solans-Laque, R.
    Callejas-Rubio, J. L.
    Ortego, N.
    Fernandez-Diaz, C.
    Rubio Romero, E.
    Garcia Morillo, S.
    Minguez, M.
    Fernandez-Carballido, C.
    De Miguel, E.
    Melchor, S.
    Salgado-Perez, E.
    Bravo, B.
    Romero-Yuste, S.
    Salvatierra, J.
    Hidalgo, C.
    Manrique Arija, S.
    Romero-Gomez, C.
    Moya, P.
    Alvarez-Rivas, N.
    Mendizabal, J.
    Ortiz Sanjuan, F. M.
    Perez de Pedro, I.
    Loricera, J.
    Castaneda, S.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1074 - 1075
  • [30] Refractory Celiac Disease: Epidemiology and Clinical Manifestations
    Malamut, Georgia
    Cellier, Christophe
    DIGESTIVE DISEASES, 2015, 33 (02) : 221 - 226
12345